Form 4 for DWTX Dogwood Therapeutics, Inc.
Accepted 2022-05-24 00:00:00 ET · period of report 2022-05-23 · accession 0001415889-22-005567 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-24 | 2022-05-23 | DWTX | Duncan Gregory Scott | CEO, Dir | P - Purchase | $4.52 | +7,500 | 32.5K | +30% | +$33.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-23 | P | A | 7,500 | $4.52 | 32,461 | D | — | — |